The Oswaldo Cruz Foundation (Fiocruz) is Latin America's leading institution for health science and technology. Established in 1900, it conducts research, promotes technological development, produces vaccines and other biological products, provides education and training, and delivers specialized reference services for Brazil's Unified Health System (SUS). In Pernambuco, Fiocruz is represented by the Aggeu Magalhães Institute (IAM). Founded in 1950, IAM is a reference center for endemic and neglected diseases, including schistosomiasis, lymphatic filariasis, dengue, Zika, chikungunya, and leprosy. The institute also trains master's and doctoral students and contributes to public health surveillance, serving as one of the pillars supporting and strengthening the SUS, Brazil's public healthcare system, which is coordinated at the federal level by the Ministry of Health.
IAM's mission is to generate knowledge and innovation to improve public health, particularly in Brazil's Northeast region. The institute also contributes to the development of public policies and to strengthening Brazil's Unified Health System (SUS).
IAM maintains a strong tradition of research on diseases such as schistosomiasis, lymphatic filariasis, leprosy, and arboviral diseases, including dengue, Zika, and chikungunya, which continue to pose major public health challenges in the region.
IAM's workforce is organized into six main departments: Entomology, Immunology, Microbiology, Parasitology, Public Health, and Virology and Experimental Therapy. The institute also provides specialized reference services for Brazil's Unified Health System (SUS).
IAM is an important education and training center, offering stricto sensu graduate programs (including master's and doctoral degrees) in Biosciences and Biotechnology in Health and Public Health. These programs are available in academic and professional formats and contribute to the training of researchers and professionals working within Brazil's Unified Health System (SUS).